Literature DB >> 2051319

Interaction of prostaglandin E1 with alpha-cyclodextrin in aqueous systems: stability of the inclusion complex.

M Wiese1, H P Cordes, H Chi, J K Seydel, T Backensfeld, B W Müller.   

Abstract

Prostavasin, an inclusion complex of prostaglandin E1 (PGE1) with alpha-cyclodextrin (alpha-CD), is used in the therapy of thrombosis. Nuclear magnetic resonance measurements have been made to study the interaction of PGE1 with alpha-CD. The observed interaction (chemical shift) and the derived dissociation constant prove that only weak interaction forces are operative and that complete dissociation occurs upon dilution.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051319     DOI: 10.1002/jps.2600800213

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).

Authors:  Vivek Gupta; Marauo Davis; Louisa J Hope-Weeks; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2011-04-06       Impact factor: 4.200

2.  Complexation of microcystins and nodularin by cyclodextrins in aqueous solution, a potential removal strategy.

Authors:  Lin Chen; Dionysios D Dionysiou; Kevin O'Shea
Journal:  Environ Sci Technol       Date:  2011-02-15       Impact factor: 9.028

3.  NMR studies of the inclusion complex of cloprostenol sodium salt with beta-cyclodextrin in aqueous solution.

Authors:  Hyun Suk Whang; Franck A P Vendeix; Hanna S Gracz; John Gadsby; Alan Tonelli
Journal:  Pharm Res       Date:  2007-12-05       Impact factor: 4.200

4.  Alprostadil suppresses angiogenesis in vitro and in vivo in the murine Matrigel plug assay.

Authors:  Maria Grazia Cattaneo; Sandra Pola; Valeria Dehò; Anna Maria Sanguini; Lucia Maria Vicentini
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

5.  Synthesis of uniform cyclodextrin thioethers to transport hydrophobic drugs.

Authors:  Lisa F Becker; Dennis H Schwarz; Gerhard Wenz
Journal:  Beilstein J Org Chem       Date:  2014-12-09       Impact factor: 2.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.